ABT vs TDC · P/E 25, rev $44.33B vs P/E 7.3, rev $854.0M
Abbott Laboratories (ABT) versus Teradata Corp (TDC) — a side-by-side from cached financials, not a winner call.
Abbott Laboratories (ABT) is a medical devices company listed on NYSE.
Teradata Corp (TDC) is a software - infrastructure company listed on NYSE.
Latest reported ABT revenue for 2025-12-31 was $44.33B. Net income was $6.52B. Revenue was up 5.7% from 2024-12-31 to 2025-12-31. ABT currently screens at market cap $154.15B and trailing P/E 24.8.
Latest reported TDC revenue for 2026-06-30 was $854.0M. Net income was $381.0M. Revenue was up 92.3% from 2026-03-31 to 2026-06-30. TDC currently screens at market cap $2.99B and trailing P/E 7.3.
ABT currently screens at market cap $154.15B and trailing P/E 24.8. TDC currently screens at market cap $2.99B and trailing P/E 7.3.
Not investment advice. Open the ABT and TDC stock pages for the full models.
Not investment advice.